Navigation Links
Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AACR Cancer Meeting
Date:4/4/2011

ORLANDO, Fla., April 4, 2011 /PRNewswire/ -- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg Pharma, Inc. group along with Berg Biosystems and Berg Diagnostics today presented groundbreaking insight into seminal work performed by Nobel Laureate, Otto Warburg.  The Warburg Hypothesis asserts that increased utilization of anaerobic respiration and production of lactate is negotiated by cancer cells in return for evasion of apoptosis, programmed cell death and other key characteristics of a healthy cell such as normally functioning mitochondria, the cell's energy and metabolic headquarters.  This area of research has become of intense importance to medical research in the past decade for many disease states.

(Logo: http://photos.prnewswire.com/prnh/20110404/CL76842LOGO)

The use of the Berg Biosystems Interrogative Biology™ discovery platform was a vital asset in enabling the biological intelligence necessary to demonstrate that the molecule ubidecarenone, a coenzyme that shuttles electrons though mitochondria was depleted in cancer cells but strikingly created a shift from dependency of lactate production to create a "breach of contract" between the cancer cell and its preferred metabolic environment.  Dr. Ralph Weichselbaum, D.K. Ludwig Professor and Chairman of Radiation and Cellular Oncology at the University of Chicago Pritzker School of Medicine commented, "I have been very intrigued and highly impressed with Cytotech's innovation and overall approach using the Berg systems biology platform to develop a whole a new avenue of therapeutic drug discovery."

Original discoverer, Niven R. Narain, now President and CTO of Berg Biosystems in Boston, founding CTO of Cytotech Labs, and former Director of Cutaneous Oncology Research at the University of Miami Miller School of Medicine, where the seminal research on cancer began stated, "It is humbling to carry o
'/>"/>

SOURCE Cytotech Labs
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimers Disease
2. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
3. Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
4. New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies
5. Reportlinker Adds Advances in SPECT Imaging (Technical Insights)
6. NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges
7. New Ultra-Clear Akro Insight Bins From A Plus Warehouse Ideal for Healthcare Industry
8. UBM TechInsights Issues Warning to Medical Devices Industry About Possible Obsolescence as Reliance on Smartphones Increases
9. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
10. New Research Provides Insight Into How Doctors View Effectiveness, Quality and Safety of Generic Medications
11. Reportlinker Adds Forecast Insight: Antihypertensives - Fixed-dose combinations fail to offset generic erosion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... R.I. , Sept. 19, 2014 Larry ... CVS ), will speak before the National Press ... will discuss the company,s recent move to stop selling tobacco ... shape the future of health. "Dramatic changes in ... health care providers and government," Merlo has said. "CVS Health ...
(Date:9/19/2014)... -- Alere Inc. (NYSE: ALR ), a global ... in support of President Barack Obama,s Executive ... leader in rapid diagnostics for infectious disease, we commend ... the serious threat of antibiotic resistance. We look forward ... to promote the development of rapid point-of-care tests that, ...
(Date:9/19/2014)... 19, 2014  Lpath, Inc. (NASDAQ: ... therapeutics, announced today that it has entered into ... common stock and 3,605,042 unregistered warrants in a ... one registered share of common stock and one ... common stock will be $3.475.  The warrants have ...
Breaking Medicine Technology:CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... Surgeons at Self Regional Healthcare,s South Carolina Spine Center ... variety of spinal conditions in its new advanced surgical ... Already recognized by leading health care ratings organization ... continues its commitment to advanced spinal care by becoming ...
... announced today the company has reached another major milestone ... management team roster. DiFUSION Technologies is ... commercialization of its proprietary CleanFUZE ™ anti-microbial technology ... line of Posterior Interbody products. "In ...
Cached Medicine Technology:Self Regional Healthcare Becomes First in the Southeast to Treat Spine Patients Using Advanced Integrated Operating Room Technology From Brainlab 2DiFUSION Technologies Adds Accomplished Senior Management Team 2DiFUSION Technologies Adds Accomplished Senior Management Team 3DiFUSION Technologies Adds Accomplished Senior Management Team 4DiFUSION Technologies Adds Accomplished Senior Management Team 5
(Date:9/19/2014)... Pregnant women who live in leafy, green neighborhoods are less ... new study suggests. Researchers analyzed data from more than ... who lived in a neighborhood with plenty of trees, grass ... very preterm birth (before 30 weeks) and a 13 percent ... Babies born to mothers who lived in greener neighborhoods ...
(Date:9/19/2014)... Alan Mozes HealthDay Reporter ... patients burdened by stress and family conflicts before surgery ... operation, a new study suggests. Investigators found that ... a nearly three times greater risk for complications compared ... life. "We,ve long known that patient quality of ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 MetroMD, a leading ... the “God Particle” of human health. This therapy has grown ... making the therapy more effective, safe and dependable. It has ... them an opportunity to live a very healthy and active ... concept of HGH therapy, a senior therapist at MetroMD said, ...
(Date:9/19/2014)... In partnership with Raw Beauty NYC, ... of the project’s social media efforts. StudioPMG is honored to ... the perception of beauty as it applies to disabled women. ... by Shelly Baer and Vanessa Silberman, who wanted to create ... beautiful. Ginny Dixon, Wendy Crawford, Susan Solman and Sabrina Cohen ...
(Date:9/19/2014)... to reducing poverty that help children and their ... and foundations. By combining education and training for ... that offer a path out of poverty with ... programs aim to improve the life opportunities of ... from the National Center for Children in Poverty ...
Breaking Medicine News(10 mins):Health News:Do Greener Neighborhoods Produce Healthier Babies? 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:OC Healthcare Agency StudioPMG Partners with The Raw Beauty Project ™ NYC 2014 2Health News:A two generation lens: Current state policies fail to support families with young children 2
... Jan. 31 (HealthDay News) -- Super Bowl fans, beware: ... and the Green Bay Packers could be a killer, ... withstand the emotional stress that comes with watching the ... risk appears real, a Los Angeles-based study team cautions, ...
... bacteria to build an extra natural layer of nanoparticle-like armour ... a startlingly simple way to give drug bearing polymer vesicles ... The Warwick researchers have been able to decorate ... new strategy in the design of vehicles for drug release, ...
... is a pathological syndrome that is usually classified into ... the Milwaukee criteria. However, this classification has some drawbacks ... classification and failure to properly guide diagnosis and treatment. ... in the World Journal of Gastroenterology addresses ...
... Oncology (ISCO) will collaborate to publish Cellular Oncology ... the official journal of ISCO and publishes original papers ... It was previously published by IOS Press. ... clinical disciplines involved in basic and translational cancer research ...
... , SATURDAY, Jan. 29 (HealthDay News) -- An ... decided on Friday that electroconvulsive (also known as "electroshock") ... as other medical devices entering the market. ... decades-old controversy surrounding the psychiatric treatment, which some patients ...
... Jan. 30 (HealthDay News) -- It may not be news to those ... reports that if you,re aboard a ship, looking at the horizon can ... investigators compared a group of crew members as they stood on land ... front of them and then a far-off object -- a distant mountain ...
Cached Medicine News:Health News:Super Bowl Loss Really a Heart Stopper for Some Fans 2Health News:Super Bowl Loss Really a Heart Stopper for Some Fans 3Health News:Plankton inspires creation of stealth armor for slow-release microscopic drug vehicles 2Health News:Springer to publish Cellular Oncology 2Health News:FDA Panel Recommends Testing of Electroshock Devices 2Health News:FDA Panel Recommends Testing of Electroshock Devices 3Health News:FDA Panel Recommends Testing of Electroshock Devices 4
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... Coagulation tubes contain a buffered ... available with a citrate concentration ... 0.129 mol/l (3.8%). The mixing ... solution to 9 parts blood. ...
... are available in two versions. ... a clotting activator and is ... serum is required for testing ... is suitable where the testing ...
Medicine Products: